Global Recombinant Activated Coagulation Factor VII Market Growth 2023-2029

The report requires updating with new data and is sent in 48 hours after order is placed.
Coagulation Factor VIIa, recombinant is a coagulation factor indicated for: Treatment of bleeding episodes and perioperative management in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, and Glanzmann’s thrombasthenia with refractoriness to platelet transfusions, with or without antibodies to platelets
LPI (LP Information)' newest research report, the “Recombinant Activated Coagulation Factor VII Industry Forecast” looks at past sales and reviews total world Recombinant Activated Coagulation Factor VII sales in 2022, providing a comprehensive analysis by region and market sector of projected Recombinant Activated Coagulation Factor VII sales for 2023 through 2029. With Recombinant Activated Coagulation Factor VII sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Activated Coagulation Factor VII industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Activated Coagulation Factor VII landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Activated Coagulation Factor VII portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Recombinant Activated Coagulation Factor VII market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Activated Coagulation Factor VII and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Activated Coagulation Factor VII.
The global Recombinant Activated Coagulation Factor VII market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Recombinant Activated Coagulation Factor VII is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Recombinant Activated Coagulation Factor VII is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Recombinant Activated Coagulation Factor VII is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Recombinant Activated Coagulation Factor VII players cover Novo Nordisk, LFB SA HEMA Biologics and AryoGen Pharmed, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Activated Coagulation Factor VII market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Recombinant Activated Coagulation Factor VII market?
What factors are driving Recombinant Activated Coagulation Factor VII market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Activated Coagulation Factor VII market opportunities vary by end market size?
How does Recombinant Activated Coagulation Factor VII break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Coagulation Factor VIIa, recombinant is a coagulation factor indicated for: Treatment of bleeding episodes and perioperative management in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, and Glanzmann’s thrombasthenia with refractoriness to platelet transfusions, with or without antibodies to platelets
LPI (LP Information)' newest research report, the “Recombinant Activated Coagulation Factor VII Industry Forecast” looks at past sales and reviews total world Recombinant Activated Coagulation Factor VII sales in 2022, providing a comprehensive analysis by region and market sector of projected Recombinant Activated Coagulation Factor VII sales for 2023 through 2029. With Recombinant Activated Coagulation Factor VII sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Activated Coagulation Factor VII industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Activated Coagulation Factor VII landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Activated Coagulation Factor VII portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Recombinant Activated Coagulation Factor VII market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Activated Coagulation Factor VII and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Activated Coagulation Factor VII.
The global Recombinant Activated Coagulation Factor VII market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Recombinant Activated Coagulation Factor VII is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Recombinant Activated Coagulation Factor VII is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Recombinant Activated Coagulation Factor VII is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Recombinant Activated Coagulation Factor VII players cover Novo Nordisk, LFB SA HEMA Biologics and AryoGen Pharmed, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Activated Coagulation Factor VII market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Vial
- Prefilled Syringe
- Hemophilia A
- Hemophilia B
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novo Nordisk
- LFB SA HEMA Biologics
- AryoGen Pharmed
What is the 10-year outlook for the global Recombinant Activated Coagulation Factor VII market?
What factors are driving Recombinant Activated Coagulation Factor VII market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Activated Coagulation Factor VII market opportunities vary by end market size?
How does Recombinant Activated Coagulation Factor VII break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Activated Coagulation Factor VII Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Recombinant Activated Coagulation Factor VII by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Recombinant Activated Coagulation Factor VII by Country/Region, 2018, 2022 & 2029
2.2 Recombinant Activated Coagulation Factor VII Segment by Type
2.2.1 Vial
2.2.2 Prefilled Syringe
2.3 Recombinant Activated Coagulation Factor VII Sales by Type
2.3.1 Global Recombinant Activated Coagulation Factor VII Sales Market Share by Type (2018-2023)
2.3.2 Global Recombinant Activated Coagulation Factor VII Revenue and Market Share by Type (2018-2023)
2.3.3 Global Recombinant Activated Coagulation Factor VII Sale Price by Type (2018-2023)
2.4 Recombinant Activated Coagulation Factor VII Segment by Application
2.4.1 Hemophilia A
2.4.2 Hemophilia B
2.4.3 Other
2.5 Recombinant Activated Coagulation Factor VII Sales by Application
2.5.1 Global Recombinant Activated Coagulation Factor VII Sale Market Share by Application (2018-2023)
2.5.2 Global Recombinant Activated Coagulation Factor VII Revenue and Market Share by Application (2018-2023)
2.5.3 Global Recombinant Activated Coagulation Factor VII Sale Price by Application (2018-2023)
3 GLOBAL RECOMBINANT ACTIVATED COAGULATION FACTOR VII BY COMPANY
3.1 Global Recombinant Activated Coagulation Factor VII Breakdown Data by Company
3.1.1 Global Recombinant Activated Coagulation Factor VII Annual Sales by Company (2018-2023)
3.1.2 Global Recombinant Activated Coagulation Factor VII Sales Market Share by Company (2018-2023)
3.2 Global Recombinant Activated Coagulation Factor VII Annual Revenue by Company (2018-2023)
3.2.1 Global Recombinant Activated Coagulation Factor VII Revenue by Company (2018-2023)
3.2.2 Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Company (2018-2023)
3.3 Global Recombinant Activated Coagulation Factor VII Sale Price by Company
3.4 Key Manufacturers Recombinant Activated Coagulation Factor VII Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Activated Coagulation Factor VII Product Location Distribution
3.4.2 Players Recombinant Activated Coagulation Factor VII Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RECOMBINANT ACTIVATED COAGULATION FACTOR VII BY GEOGRAPHIC REGION
4.1 World Historic Recombinant Activated Coagulation Factor VII Market Size by Geographic Region (2018-2023)
4.1.1 Global Recombinant Activated Coagulation Factor VII Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Recombinant Activated Coagulation Factor VII Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Recombinant Activated Coagulation Factor VII Market Size by Country/Region (2018-2023)
4.2.1 Global Recombinant Activated Coagulation Factor VII Annual Sales by Country/Region (2018-2023)
4.2.2 Global Recombinant Activated Coagulation Factor VII Annual Revenue by Country/Region (2018-2023)
4.3 Americas Recombinant Activated Coagulation Factor VII Sales Growth
4.4 APAC Recombinant Activated Coagulation Factor VII Sales Growth
4.5 Europe Recombinant Activated Coagulation Factor VII Sales Growth
4.6 Middle East & Africa Recombinant Activated Coagulation Factor VII Sales Growth
5 AMERICAS
5.1 Americas Recombinant Activated Coagulation Factor VII Sales by Country
5.1.1 Americas Recombinant Activated Coagulation Factor VII Sales by Country (2018-2023)
5.1.2 Americas Recombinant Activated Coagulation Factor VII Revenue by Country (2018-2023)
5.2 Americas Recombinant Activated Coagulation Factor VII Sales by Type
5.3 Americas Recombinant Activated Coagulation Factor VII Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Activated Coagulation Factor VII Sales by Region
6.1.1 APAC Recombinant Activated Coagulation Factor VII Sales by Region (2018-2023)
6.1.2 APAC Recombinant Activated Coagulation Factor VII Revenue by Region (2018-2023)
6.2 APAC Recombinant Activated Coagulation Factor VII Sales by Type
6.3 APAC Recombinant Activated Coagulation Factor VII Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant Activated Coagulation Factor VII by Country
7.1.1 Europe Recombinant Activated Coagulation Factor VII Sales by Country (2018-2023)
7.1.2 Europe Recombinant Activated Coagulation Factor VII Revenue by Country (2018-2023)
7.2 Europe Recombinant Activated Coagulation Factor VII Sales by Type
7.3 Europe Recombinant Activated Coagulation Factor VII Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Activated Coagulation Factor VII by Country
8.1.1 Middle East & Africa Recombinant Activated Coagulation Factor VII Sales by Country (2018-2023)
8.1.2 Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue by Country (2018-2023)
8.2 Middle East & Africa Recombinant Activated Coagulation Factor VII Sales by Type
8.3 Middle East & Africa Recombinant Activated Coagulation Factor VII Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Activated Coagulation Factor VII
10.3 Manufacturing Process Analysis of Recombinant Activated Coagulation Factor VII
10.4 Industry Chain Structure of Recombinant Activated Coagulation Factor VII
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Activated Coagulation Factor VII Distributors
11.3 Recombinant Activated Coagulation Factor VII Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT ACTIVATED COAGULATION FACTOR VII BY GEOGRAPHIC REGION
12.1 Global Recombinant Activated Coagulation Factor VII Market Size Forecast by Region
12.1.1 Global Recombinant Activated Coagulation Factor VII Forecast by Region (2024-2029)
12.1.2 Global Recombinant Activated Coagulation Factor VII Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Recombinant Activated Coagulation Factor VII Forecast by Type
12.7 Global Recombinant Activated Coagulation Factor VII Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Recombinant Activated Coagulation Factor VII Product Portfolios and Specifications
13.1.3 Novo Nordisk Recombinant Activated Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 LFB SA HEMA Biologics
13.2.1 LFB SA HEMA Biologics Company Information
13.2.2 LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Product Portfolios and Specifications
13.2.3 LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 LFB SA HEMA Biologics Main Business Overview
13.2.5 LFB SA HEMA Biologics Latest Developments
13.3 AryoGen Pharmed
13.3.1 AryoGen Pharmed Company Information
13.3.2 AryoGen Pharmed Recombinant Activated Coagulation Factor VII Product Portfolios and Specifications
13.3.3 AryoGen Pharmed Recombinant Activated Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 AryoGen Pharmed Main Business Overview
13.3.5 AryoGen Pharmed Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Activated Coagulation Factor VII Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Recombinant Activated Coagulation Factor VII by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Recombinant Activated Coagulation Factor VII by Country/Region, 2018, 2022 & 2029
2.2 Recombinant Activated Coagulation Factor VII Segment by Type
2.2.1 Vial
2.2.2 Prefilled Syringe
2.3 Recombinant Activated Coagulation Factor VII Sales by Type
2.3.1 Global Recombinant Activated Coagulation Factor VII Sales Market Share by Type (2018-2023)
2.3.2 Global Recombinant Activated Coagulation Factor VII Revenue and Market Share by Type (2018-2023)
2.3.3 Global Recombinant Activated Coagulation Factor VII Sale Price by Type (2018-2023)
2.4 Recombinant Activated Coagulation Factor VII Segment by Application
2.4.1 Hemophilia A
2.4.2 Hemophilia B
2.4.3 Other
2.5 Recombinant Activated Coagulation Factor VII Sales by Application
2.5.1 Global Recombinant Activated Coagulation Factor VII Sale Market Share by Application (2018-2023)
2.5.2 Global Recombinant Activated Coagulation Factor VII Revenue and Market Share by Application (2018-2023)
2.5.3 Global Recombinant Activated Coagulation Factor VII Sale Price by Application (2018-2023)
3 GLOBAL RECOMBINANT ACTIVATED COAGULATION FACTOR VII BY COMPANY
3.1 Global Recombinant Activated Coagulation Factor VII Breakdown Data by Company
3.1.1 Global Recombinant Activated Coagulation Factor VII Annual Sales by Company (2018-2023)
3.1.2 Global Recombinant Activated Coagulation Factor VII Sales Market Share by Company (2018-2023)
3.2 Global Recombinant Activated Coagulation Factor VII Annual Revenue by Company (2018-2023)
3.2.1 Global Recombinant Activated Coagulation Factor VII Revenue by Company (2018-2023)
3.2.2 Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Company (2018-2023)
3.3 Global Recombinant Activated Coagulation Factor VII Sale Price by Company
3.4 Key Manufacturers Recombinant Activated Coagulation Factor VII Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Activated Coagulation Factor VII Product Location Distribution
3.4.2 Players Recombinant Activated Coagulation Factor VII Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RECOMBINANT ACTIVATED COAGULATION FACTOR VII BY GEOGRAPHIC REGION
4.1 World Historic Recombinant Activated Coagulation Factor VII Market Size by Geographic Region (2018-2023)
4.1.1 Global Recombinant Activated Coagulation Factor VII Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Recombinant Activated Coagulation Factor VII Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Recombinant Activated Coagulation Factor VII Market Size by Country/Region (2018-2023)
4.2.1 Global Recombinant Activated Coagulation Factor VII Annual Sales by Country/Region (2018-2023)
4.2.2 Global Recombinant Activated Coagulation Factor VII Annual Revenue by Country/Region (2018-2023)
4.3 Americas Recombinant Activated Coagulation Factor VII Sales Growth
4.4 APAC Recombinant Activated Coagulation Factor VII Sales Growth
4.5 Europe Recombinant Activated Coagulation Factor VII Sales Growth
4.6 Middle East & Africa Recombinant Activated Coagulation Factor VII Sales Growth
5 AMERICAS
5.1 Americas Recombinant Activated Coagulation Factor VII Sales by Country
5.1.1 Americas Recombinant Activated Coagulation Factor VII Sales by Country (2018-2023)
5.1.2 Americas Recombinant Activated Coagulation Factor VII Revenue by Country (2018-2023)
5.2 Americas Recombinant Activated Coagulation Factor VII Sales by Type
5.3 Americas Recombinant Activated Coagulation Factor VII Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Activated Coagulation Factor VII Sales by Region
6.1.1 APAC Recombinant Activated Coagulation Factor VII Sales by Region (2018-2023)
6.1.2 APAC Recombinant Activated Coagulation Factor VII Revenue by Region (2018-2023)
6.2 APAC Recombinant Activated Coagulation Factor VII Sales by Type
6.3 APAC Recombinant Activated Coagulation Factor VII Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant Activated Coagulation Factor VII by Country
7.1.1 Europe Recombinant Activated Coagulation Factor VII Sales by Country (2018-2023)
7.1.2 Europe Recombinant Activated Coagulation Factor VII Revenue by Country (2018-2023)
7.2 Europe Recombinant Activated Coagulation Factor VII Sales by Type
7.3 Europe Recombinant Activated Coagulation Factor VII Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Activated Coagulation Factor VII by Country
8.1.1 Middle East & Africa Recombinant Activated Coagulation Factor VII Sales by Country (2018-2023)
8.1.2 Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue by Country (2018-2023)
8.2 Middle East & Africa Recombinant Activated Coagulation Factor VII Sales by Type
8.3 Middle East & Africa Recombinant Activated Coagulation Factor VII Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Activated Coagulation Factor VII
10.3 Manufacturing Process Analysis of Recombinant Activated Coagulation Factor VII
10.4 Industry Chain Structure of Recombinant Activated Coagulation Factor VII
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Activated Coagulation Factor VII Distributors
11.3 Recombinant Activated Coagulation Factor VII Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT ACTIVATED COAGULATION FACTOR VII BY GEOGRAPHIC REGION
12.1 Global Recombinant Activated Coagulation Factor VII Market Size Forecast by Region
12.1.1 Global Recombinant Activated Coagulation Factor VII Forecast by Region (2024-2029)
12.1.2 Global Recombinant Activated Coagulation Factor VII Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Recombinant Activated Coagulation Factor VII Forecast by Type
12.7 Global Recombinant Activated Coagulation Factor VII Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Recombinant Activated Coagulation Factor VII Product Portfolios and Specifications
13.1.3 Novo Nordisk Recombinant Activated Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 LFB SA HEMA Biologics
13.2.1 LFB SA HEMA Biologics Company Information
13.2.2 LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Product Portfolios and Specifications
13.2.3 LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 LFB SA HEMA Biologics Main Business Overview
13.2.5 LFB SA HEMA Biologics Latest Developments
13.3 AryoGen Pharmed
13.3.1 AryoGen Pharmed Company Information
13.3.2 AryoGen Pharmed Recombinant Activated Coagulation Factor VII Product Portfolios and Specifications
13.3.3 AryoGen Pharmed Recombinant Activated Coagulation Factor VII Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 AryoGen Pharmed Main Business Overview
13.3.5 AryoGen Pharmed Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Recombinant Activated Coagulation Factor VII Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Recombinant Activated Coagulation Factor VII Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Vial
Table 4. Major Players of Prefilled Syringe
Table 5. Global Recombinant Activated Coagulation Factor VII Sales by Type (2018-2023) & (Units)
Table 6. Global Recombinant Activated Coagulation Factor VII Sales Market Share by Type (2018-2023)
Table 7. Global Recombinant Activated Coagulation Factor VII Revenue by Type (2018-2023) & ($ million)
Table 8. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Type (2018-2023)
Table 9. Global Recombinant Activated Coagulation Factor VII Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Recombinant Activated Coagulation Factor VII Sales by Application (2018-2023) & (Units)
Table 11. Global Recombinant Activated Coagulation Factor VII Sales Market Share by Application (2018-2023)
Table 12. Global Recombinant Activated Coagulation Factor VII Revenue by Application (2018-2023)
Table 13. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Application (2018-2023)
Table 14. Global Recombinant Activated Coagulation Factor VII Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Recombinant Activated Coagulation Factor VII Sales by Company (2018-2023) & (Units)
Table 16. Global Recombinant Activated Coagulation Factor VII Sales Market Share by Company (2018-2023)
Table 17. Global Recombinant Activated Coagulation Factor VII Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Company (2018-2023)
Table 19. Global Recombinant Activated Coagulation Factor VII Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Recombinant Activated Coagulation Factor VII Producing Area Distribution and Sales Area
Table 21. Players Recombinant Activated Coagulation Factor VII Products Offered
Table 22. Recombinant Activated Coagulation Factor VII Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Recombinant Activated Coagulation Factor VII Sales by Geographic Region (2018-2023) & (Units)
Table 26. Global Recombinant Activated Coagulation Factor VII Sales Market Share Geographic Region (2018-2023)
Table 27. Global Recombinant Activated Coagulation Factor VII Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Recombinant Activated Coagulation Factor VII Sales by Country/Region (2018-2023) & (Units)
Table 30. Global Recombinant Activated Coagulation Factor VII Sales Market Share by Country/Region (2018-2023)
Table 31. Global Recombinant Activated Coagulation Factor VII Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Recombinant Activated Coagulation Factor VII Sales by Country (2018-2023) & (Units)
Table 34. Americas Recombinant Activated Coagulation Factor VII Sales Market Share by Country (2018-2023)
Table 35. Americas Recombinant Activated Coagulation Factor VII Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Recombinant Activated Coagulation Factor VII Revenue Market Share by Country (2018-2023)
Table 37. Americas Recombinant Activated Coagulation Factor VII Sales by Type (2018-2023) & (Units)
Table 38. Americas Recombinant Activated Coagulation Factor VII Sales by Application (2018-2023) & (Units)
Table 39. APAC Recombinant Activated Coagulation Factor VII Sales by Region (2018-2023) & (Units)
Table 40. APAC Recombinant Activated Coagulation Factor VII Sales Market Share by Region (2018-2023)
Table 41. APAC Recombinant Activated Coagulation Factor VII Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Recombinant Activated Coagulation Factor VII Revenue Market Share by Region (2018-2023)
Table 43. APAC Recombinant Activated Coagulation Factor VII Sales by Type (2018-2023) & (Units)
Table 44. APAC Recombinant Activated Coagulation Factor VII Sales by Application (2018-2023) & (Units)
Table 45. Europe Recombinant Activated Coagulation Factor VII Sales by Country (2018-2023) & (Units)
Table 46. Europe Recombinant Activated Coagulation Factor VII Sales Market Share by Country (2018-2023)
Table 47. Europe Recombinant Activated Coagulation Factor VII Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Recombinant Activated Coagulation Factor VII Revenue Market Share by Country (2018-2023)
Table 49. Europe Recombinant Activated Coagulation Factor VII Sales by Type (2018-2023) & (Units)
Table 50. Europe Recombinant Activated Coagulation Factor VII Sales by Application (2018-2023) & (Units)
Table 51. Middle East & Africa Recombinant Activated Coagulation Factor VII Sales by Country (2018-2023) & (Units)
Table 52. Middle East & Africa Recombinant Activated Coagulation Factor VII Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Recombinant Activated Coagulation Factor VII Sales by Type (2018-2023) & (Units)
Table 56. Middle East & Africa Recombinant Activated Coagulation Factor VII Sales by Application (2018-2023) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Recombinant Activated Coagulation Factor VII
Table 58. Key Market Challenges & Risks of Recombinant Activated Coagulation Factor VII
Table 59. Key Industry Trends of Recombinant Activated Coagulation Factor VII
Table 60. Recombinant Activated Coagulation Factor VII Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Recombinant Activated Coagulation Factor VII Distributors List
Table 63. Recombinant Activated Coagulation Factor VII Customer List
Table 64. Global Recombinant Activated Coagulation Factor VII Sales Forecast by Region (2024-2029) & (Units)
Table 65. Global Recombinant Activated Coagulation Factor VII Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Recombinant Activated Coagulation Factor VII Sales Forecast by Country (2024-2029) & (Units)
Table 67. Americas Recombinant Activated Coagulation Factor VII Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Recombinant Activated Coagulation Factor VII Sales Forecast by Region (2024-2029) & (Units)
Table 69. APAC Recombinant Activated Coagulation Factor VII Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Recombinant Activated Coagulation Factor VII Sales Forecast by Country (2024-2029) & (Units)
Table 71. Europe Recombinant Activated Coagulation Factor VII Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Recombinant Activated Coagulation Factor VII Sales Forecast by Country (2024-2029) & (Units)
Table 73. Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Recombinant Activated Coagulation Factor VII Sales Forecast by Type (2024-2029) & (Units)
Table 75. Global Recombinant Activated Coagulation Factor VII Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Recombinant Activated Coagulation Factor VII Sales Forecast by Application (2024-2029) & (Units)
Table 77. Global Recombinant Activated Coagulation Factor VII Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Novo Nordisk Basic Information, Recombinant Activated Coagulation Factor VII Manufacturing Base, Sales Area and Its Competitors
Table 79. Novo Nordisk Recombinant Activated Coagulation Factor VII Product Portfolios and Specifications
Table 80. Novo Nordisk Recombinant Activated Coagulation Factor VII Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Novo Nordisk Main Business
Table 82. Novo Nordisk Latest Developments
Table 83. LFB SA HEMA Biologics Basic Information, Recombinant Activated Coagulation Factor VII Manufacturing Base, Sales Area and Its Competitors
Table 84. LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Product Portfolios and Specifications
Table 85. LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. LFB SA HEMA Biologics Main Business
Table 87. LFB SA HEMA Biologics Latest Developments
Table 88. AryoGen Pharmed Basic Information, Recombinant Activated Coagulation Factor VII Manufacturing Base, Sales Area and Its Competitors
Table 89. AryoGen Pharmed Recombinant Activated Coagulation Factor VII Product Portfolios and Specifications
Table 90. AryoGen Pharmed Recombinant Activated Coagulation Factor VII Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. AryoGen Pharmed Main Business
Table 92. AryoGen Pharmed Latest Developments
Table 1. Recombinant Activated Coagulation Factor VII Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Recombinant Activated Coagulation Factor VII Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Vial
Table 4. Major Players of Prefilled Syringe
Table 5. Global Recombinant Activated Coagulation Factor VII Sales by Type (2018-2023) & (Units)
Table 6. Global Recombinant Activated Coagulation Factor VII Sales Market Share by Type (2018-2023)
Table 7. Global Recombinant Activated Coagulation Factor VII Revenue by Type (2018-2023) & ($ million)
Table 8. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Type (2018-2023)
Table 9. Global Recombinant Activated Coagulation Factor VII Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Recombinant Activated Coagulation Factor VII Sales by Application (2018-2023) & (Units)
Table 11. Global Recombinant Activated Coagulation Factor VII Sales Market Share by Application (2018-2023)
Table 12. Global Recombinant Activated Coagulation Factor VII Revenue by Application (2018-2023)
Table 13. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Application (2018-2023)
Table 14. Global Recombinant Activated Coagulation Factor VII Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Recombinant Activated Coagulation Factor VII Sales by Company (2018-2023) & (Units)
Table 16. Global Recombinant Activated Coagulation Factor VII Sales Market Share by Company (2018-2023)
Table 17. Global Recombinant Activated Coagulation Factor VII Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Company (2018-2023)
Table 19. Global Recombinant Activated Coagulation Factor VII Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Recombinant Activated Coagulation Factor VII Producing Area Distribution and Sales Area
Table 21. Players Recombinant Activated Coagulation Factor VII Products Offered
Table 22. Recombinant Activated Coagulation Factor VII Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Recombinant Activated Coagulation Factor VII Sales by Geographic Region (2018-2023) & (Units)
Table 26. Global Recombinant Activated Coagulation Factor VII Sales Market Share Geographic Region (2018-2023)
Table 27. Global Recombinant Activated Coagulation Factor VII Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Recombinant Activated Coagulation Factor VII Sales by Country/Region (2018-2023) & (Units)
Table 30. Global Recombinant Activated Coagulation Factor VII Sales Market Share by Country/Region (2018-2023)
Table 31. Global Recombinant Activated Coagulation Factor VII Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Recombinant Activated Coagulation Factor VII Sales by Country (2018-2023) & (Units)
Table 34. Americas Recombinant Activated Coagulation Factor VII Sales Market Share by Country (2018-2023)
Table 35. Americas Recombinant Activated Coagulation Factor VII Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Recombinant Activated Coagulation Factor VII Revenue Market Share by Country (2018-2023)
Table 37. Americas Recombinant Activated Coagulation Factor VII Sales by Type (2018-2023) & (Units)
Table 38. Americas Recombinant Activated Coagulation Factor VII Sales by Application (2018-2023) & (Units)
Table 39. APAC Recombinant Activated Coagulation Factor VII Sales by Region (2018-2023) & (Units)
Table 40. APAC Recombinant Activated Coagulation Factor VII Sales Market Share by Region (2018-2023)
Table 41. APAC Recombinant Activated Coagulation Factor VII Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Recombinant Activated Coagulation Factor VII Revenue Market Share by Region (2018-2023)
Table 43. APAC Recombinant Activated Coagulation Factor VII Sales by Type (2018-2023) & (Units)
Table 44. APAC Recombinant Activated Coagulation Factor VII Sales by Application (2018-2023) & (Units)
Table 45. Europe Recombinant Activated Coagulation Factor VII Sales by Country (2018-2023) & (Units)
Table 46. Europe Recombinant Activated Coagulation Factor VII Sales Market Share by Country (2018-2023)
Table 47. Europe Recombinant Activated Coagulation Factor VII Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Recombinant Activated Coagulation Factor VII Revenue Market Share by Country (2018-2023)
Table 49. Europe Recombinant Activated Coagulation Factor VII Sales by Type (2018-2023) & (Units)
Table 50. Europe Recombinant Activated Coagulation Factor VII Sales by Application (2018-2023) & (Units)
Table 51. Middle East & Africa Recombinant Activated Coagulation Factor VII Sales by Country (2018-2023) & (Units)
Table 52. Middle East & Africa Recombinant Activated Coagulation Factor VII Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Recombinant Activated Coagulation Factor VII Sales by Type (2018-2023) & (Units)
Table 56. Middle East & Africa Recombinant Activated Coagulation Factor VII Sales by Application (2018-2023) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Recombinant Activated Coagulation Factor VII
Table 58. Key Market Challenges & Risks of Recombinant Activated Coagulation Factor VII
Table 59. Key Industry Trends of Recombinant Activated Coagulation Factor VII
Table 60. Recombinant Activated Coagulation Factor VII Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Recombinant Activated Coagulation Factor VII Distributors List
Table 63. Recombinant Activated Coagulation Factor VII Customer List
Table 64. Global Recombinant Activated Coagulation Factor VII Sales Forecast by Region (2024-2029) & (Units)
Table 65. Global Recombinant Activated Coagulation Factor VII Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Recombinant Activated Coagulation Factor VII Sales Forecast by Country (2024-2029) & (Units)
Table 67. Americas Recombinant Activated Coagulation Factor VII Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Recombinant Activated Coagulation Factor VII Sales Forecast by Region (2024-2029) & (Units)
Table 69. APAC Recombinant Activated Coagulation Factor VII Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Recombinant Activated Coagulation Factor VII Sales Forecast by Country (2024-2029) & (Units)
Table 71. Europe Recombinant Activated Coagulation Factor VII Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Recombinant Activated Coagulation Factor VII Sales Forecast by Country (2024-2029) & (Units)
Table 73. Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Recombinant Activated Coagulation Factor VII Sales Forecast by Type (2024-2029) & (Units)
Table 75. Global Recombinant Activated Coagulation Factor VII Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Recombinant Activated Coagulation Factor VII Sales Forecast by Application (2024-2029) & (Units)
Table 77. Global Recombinant Activated Coagulation Factor VII Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Novo Nordisk Basic Information, Recombinant Activated Coagulation Factor VII Manufacturing Base, Sales Area and Its Competitors
Table 79. Novo Nordisk Recombinant Activated Coagulation Factor VII Product Portfolios and Specifications
Table 80. Novo Nordisk Recombinant Activated Coagulation Factor VII Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Novo Nordisk Main Business
Table 82. Novo Nordisk Latest Developments
Table 83. LFB SA HEMA Biologics Basic Information, Recombinant Activated Coagulation Factor VII Manufacturing Base, Sales Area and Its Competitors
Table 84. LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Product Portfolios and Specifications
Table 85. LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. LFB SA HEMA Biologics Main Business
Table 87. LFB SA HEMA Biologics Latest Developments
Table 88. AryoGen Pharmed Basic Information, Recombinant Activated Coagulation Factor VII Manufacturing Base, Sales Area and Its Competitors
Table 89. AryoGen Pharmed Recombinant Activated Coagulation Factor VII Product Portfolios and Specifications
Table 90. AryoGen Pharmed Recombinant Activated Coagulation Factor VII Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. AryoGen Pharmed Main Business
Table 92. AryoGen Pharmed Latest Developments
LIST OF FIGURES
Figure 1. Picture of Recombinant Activated Coagulation Factor VII
Figure 2. Recombinant Activated Coagulation Factor VII Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Activated Coagulation Factor VII Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Recombinant Activated Coagulation Factor VII Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Recombinant Activated Coagulation Factor VII Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Vial
Figure 10. Product Picture of Prefilled Syringe
Figure 11. Global Recombinant Activated Coagulation Factor VII Sales Market Share by Type in 2022
Figure 12. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Type (2018-2023)
Figure 13. Recombinant Activated Coagulation Factor VII Consumed in Hemophilia A
Figure 14. Global Recombinant Activated Coagulation Factor VII Market: Hemophilia A (2018-2023) & (Units)
Figure 15. Recombinant Activated Coagulation Factor VII Consumed in Hemophilia B
Figure 16. Global Recombinant Activated Coagulation Factor VII Market: Hemophilia B (2018-2023) & (Units)
Figure 17. Recombinant Activated Coagulation Factor VII Consumed in Other
Figure 18. Global Recombinant Activated Coagulation Factor VII Market: Other (2018-2023) & (Units)
Figure 19. Global Recombinant Activated Coagulation Factor VII Sales Market Share by Application (2022)
Figure 20. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Application in 2022
Figure 21. Recombinant Activated Coagulation Factor VII Sales Market by Company in 2022 (Units)
Figure 22. Global Recombinant Activated Coagulation Factor VII Sales Market Share by Company in 2022
Figure 23. Recombinant Activated Coagulation Factor VII Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Company in 2022
Figure 25. Global Recombinant Activated Coagulation Factor VII Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Recombinant Activated Coagulation Factor VII Sales 2018-2023 (Units)
Figure 28. Americas Recombinant Activated Coagulation Factor VII Revenue 2018-2023 ($ Millions)
Figure 29. APAC Recombinant Activated Coagulation Factor VII Sales 2018-2023 (Units)
Figure 30. APAC Recombinant Activated Coagulation Factor VII Revenue 2018-2023 ($ Millions)
Figure 31. Europe Recombinant Activated Coagulation Factor VII Sales 2018-2023 (Units)
Figure 32. Europe Recombinant Activated Coagulation Factor VII Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Recombinant Activated Coagulation Factor VII Sales 2018-2023 (Units)
Figure 34. Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue 2018-2023 ($ Millions)
Figure 35. Americas Recombinant Activated Coagulation Factor VII Sales Market Share by Country in 2022
Figure 36. Americas Recombinant Activated Coagulation Factor VII Revenue Market Share by Country in 2022
Figure 37. Americas Recombinant Activated Coagulation Factor VII Sales Market Share by Type (2018-2023)
Figure 38. Americas Recombinant Activated Coagulation Factor VII Sales Market Share by Application (2018-2023)
Figure 39. United States Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Recombinant Activated Coagulation Factor VII Sales Market Share by Region in 2022
Figure 44. APAC Recombinant Activated Coagulation Factor VII Revenue Market Share by Regions in 2022
Figure 45. APAC Recombinant Activated Coagulation Factor VII Sales Market Share by Type (2018-2023)
Figure 46. APAC Recombinant Activated Coagulation Factor VII Sales Market Share by Application (2018-2023)
Figure 47. China Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Recombinant Activated Coagulation Factor VII Sales Market Share by Country in 2022
Figure 55. Europe Recombinant Activated Coagulation Factor VII Revenue Market Share by Country in 2022
Figure 56. Europe Recombinant Activated Coagulation Factor VII Sales Market Share by Type (2018-2023)
Figure 57. Europe Recombinant Activated Coagulation Factor VII Sales Market Share by Application (2018-2023)
Figure 58. Germany Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Recombinant Activated Coagulation Factor VII Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Recombinant Activated Coagulation Factor VII Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Recombinant Activated Coagulation Factor VII Sales Market Share by Application (2018-2023)
Figure 67. Egypt Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Recombinant Activated Coagulation Factor VII in 2022
Figure 73. Manufacturing Process Analysis of Recombinant Activated Coagulation Factor VII
Figure 74. Industry Chain Structure of Recombinant Activated Coagulation Factor VII
Figure 75. Channels of Distribution
Figure 76. Global Recombinant Activated Coagulation Factor VII Sales Market Forecast by Region (2024-2029)
Figure 77. Global Recombinant Activated Coagulation Factor VII Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Recombinant Activated Coagulation Factor VII Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Recombinant Activated Coagulation Factor VII Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Recombinant Activated Coagulation Factor VII Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Recombinant Activated Coagulation Factor VII Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Recombinant Activated Coagulation Factor VII
Figure 2. Recombinant Activated Coagulation Factor VII Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Activated Coagulation Factor VII Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Recombinant Activated Coagulation Factor VII Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Recombinant Activated Coagulation Factor VII Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Vial
Figure 10. Product Picture of Prefilled Syringe
Figure 11. Global Recombinant Activated Coagulation Factor VII Sales Market Share by Type in 2022
Figure 12. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Type (2018-2023)
Figure 13. Recombinant Activated Coagulation Factor VII Consumed in Hemophilia A
Figure 14. Global Recombinant Activated Coagulation Factor VII Market: Hemophilia A (2018-2023) & (Units)
Figure 15. Recombinant Activated Coagulation Factor VII Consumed in Hemophilia B
Figure 16. Global Recombinant Activated Coagulation Factor VII Market: Hemophilia B (2018-2023) & (Units)
Figure 17. Recombinant Activated Coagulation Factor VII Consumed in Other
Figure 18. Global Recombinant Activated Coagulation Factor VII Market: Other (2018-2023) & (Units)
Figure 19. Global Recombinant Activated Coagulation Factor VII Sales Market Share by Application (2022)
Figure 20. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Application in 2022
Figure 21. Recombinant Activated Coagulation Factor VII Sales Market by Company in 2022 (Units)
Figure 22. Global Recombinant Activated Coagulation Factor VII Sales Market Share by Company in 2022
Figure 23. Recombinant Activated Coagulation Factor VII Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Company in 2022
Figure 25. Global Recombinant Activated Coagulation Factor VII Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Recombinant Activated Coagulation Factor VII Sales 2018-2023 (Units)
Figure 28. Americas Recombinant Activated Coagulation Factor VII Revenue 2018-2023 ($ Millions)
Figure 29. APAC Recombinant Activated Coagulation Factor VII Sales 2018-2023 (Units)
Figure 30. APAC Recombinant Activated Coagulation Factor VII Revenue 2018-2023 ($ Millions)
Figure 31. Europe Recombinant Activated Coagulation Factor VII Sales 2018-2023 (Units)
Figure 32. Europe Recombinant Activated Coagulation Factor VII Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Recombinant Activated Coagulation Factor VII Sales 2018-2023 (Units)
Figure 34. Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue 2018-2023 ($ Millions)
Figure 35. Americas Recombinant Activated Coagulation Factor VII Sales Market Share by Country in 2022
Figure 36. Americas Recombinant Activated Coagulation Factor VII Revenue Market Share by Country in 2022
Figure 37. Americas Recombinant Activated Coagulation Factor VII Sales Market Share by Type (2018-2023)
Figure 38. Americas Recombinant Activated Coagulation Factor VII Sales Market Share by Application (2018-2023)
Figure 39. United States Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Recombinant Activated Coagulation Factor VII Sales Market Share by Region in 2022
Figure 44. APAC Recombinant Activated Coagulation Factor VII Revenue Market Share by Regions in 2022
Figure 45. APAC Recombinant Activated Coagulation Factor VII Sales Market Share by Type (2018-2023)
Figure 46. APAC Recombinant Activated Coagulation Factor VII Sales Market Share by Application (2018-2023)
Figure 47. China Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Recombinant Activated Coagulation Factor VII Sales Market Share by Country in 2022
Figure 55. Europe Recombinant Activated Coagulation Factor VII Revenue Market Share by Country in 2022
Figure 56. Europe Recombinant Activated Coagulation Factor VII Sales Market Share by Type (2018-2023)
Figure 57. Europe Recombinant Activated Coagulation Factor VII Sales Market Share by Application (2018-2023)
Figure 58. Germany Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Recombinant Activated Coagulation Factor VII Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Recombinant Activated Coagulation Factor VII Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Recombinant Activated Coagulation Factor VII Sales Market Share by Application (2018-2023)
Figure 67. Egypt Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Recombinant Activated Coagulation Factor VII Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Recombinant Activated Coagulation Factor VII in 2022
Figure 73. Manufacturing Process Analysis of Recombinant Activated Coagulation Factor VII
Figure 74. Industry Chain Structure of Recombinant Activated Coagulation Factor VII
Figure 75. Channels of Distribution
Figure 76. Global Recombinant Activated Coagulation Factor VII Sales Market Forecast by Region (2024-2029)
Figure 77. Global Recombinant Activated Coagulation Factor VII Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Recombinant Activated Coagulation Factor VII Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Recombinant Activated Coagulation Factor VII Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Recombinant Activated Coagulation Factor VII Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Recombinant Activated Coagulation Factor VII Revenue Market Share Forecast by Application (2024-2029)